Molecular recurrence signals preceded symptoms or imaging in all recurrences observed, indicating ctDNA may enable earlier intervention than conventional surveillance paradigms. Post-neoadjuvant ctDNA ...

While this health condition is not fatal on its own, it may raise the risk of complications that could be deadly.

Colon cancer is one of the most common cancers in the U.S., with more than 100,000 cases diagnosed each year. But some people ...

The dermatology practice where Brian sought treatment, like more than 400 other dermatology practices around the country, ...

Amanda Peet detailed her recent breast cancer diagnosis in a new essay, sharing that her health battle coincided with both of ...

Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program and translational research in aerodigestive cancers, outlined in an interview ...

Legendary thrash metal icon Dave Mustaine is opening up about one of the darkest chapters of his life, sharing painful ...

My dog has cancer. Not for the first time. Nor the second or third time. But for the fourth time in three years. Unlike an ...

An NJIT student is lead author of a new study that could help physicians standardize methods for diagnosing and treating squamous cell carcinoma of the colon.

Highlighting the critical role of Caris GPSai in improving cancer care. IRVING, Texas, March 20, 2026 /PRNewswire/ -- Caris ...

Adding lenvatinib to pembrolizumab improved PFS (6.2 vs 2.8 months; HR 0.64) and ORR (46.1% vs 25.4%) versus pembrolizumab alone in PD-L1 CPS ≥1 disease. Overall survival was not improved at 21.3 ...

In My Darkest Hour, out in September, will recount how music, family, and faith kept artist going during dark times ...